FindTrial
Sign In

Rapid Pathological Evaluation of Surgical Resection Specimens after Comprehensive Treatment of Hepatocellular Carcinoma Guided by Indocyanine Green Fluorescence Imaging: a prospective study

Rapid Pathological Evaluation of Surgical Resection Specimens after Comprehensive Treatment of Hepatocellular Carcinoma Guided by Indocyanine Green Fluorescence Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082814
Enrollment
Unknown
Registered
2024-04-09
Start date
2021-01-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Rapid Pathology Evaluation Group:None

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: ? Age =18 years old, regardless of gender, voluntarily participating in the study; ? Diagnosed as hepatocellular carcinoma; ? BCLC A-C or CNLC Ia-IIIb before treatment; ?Neoadjuvant therapy or conversion therapy before surgery.

Exclusion criteria

Exclusion criteria: ? Missing important clinical data; ? Surgical treatment is not feasible.

Design outcomes

Primary

MeasureTime frame
Tumor necrosis rate;Fluorescence value;—

Secondary

MeasureTime frame
Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactWang Hongguang

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

wanghongguang301@163.com+86 156 0117 0661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026